The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of an improved risk stratification scheme for stage II and III colorectal cancers through incorporation of the digital pathology biomarker QuantCRC.
 
Rish Pai
Consulting or Advisory Role - Alimentiv; Allergan; Ferring
 
Christina Wu
Honoraria - Cancer Treament Centers of America; Medscape; Oncology Learning Network; PrecisCA
Consulting or Advisory Role - Array BioPHarma; Daiichi Sankyo/Lilly; Natera; Natera; Nova Research Company; Pfizer; Seagen
Research Funding - Boston Biomedical (Inst); HUTCHMED; InhibRx (Inst); Lycera (Inst); Pfizer; RAPT Therapeutics (Inst); Seagen (Inst); Symphogen (Inst); Vaccinex (Inst)
 
Heidi E. Kosiorek
No Relationships to Disclose
 
Imon Banerjee
No Relationships to Disclose
 
Catherine E. Hagen
No Relationships to Disclose
 
Christopher P. Hartley
No Relationships to Disclose
 
Rondell P. Graham
No Relationships to Disclose
 
Bassam Bassam Sonbol
Consulting or Advisory Role - Novartis Biociencias
Research Funding - Lilly (Inst); Taiho Oncology (Inst)
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Caladrius Biosciences; Caladrius Biosciences; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio; Zai Lab
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Hao Xie
Honoraria - Mayo Clinic CME
Patents, Royalties, Other Intellectual Property - Patent application entitled "DEGRADERS OF SON OF SEVENLESS HOMOLOG 1" was filed with the United States Patent and Trademark Office on 8/11/2023.
 
Frank A. Sinicrope
Employment - MedVal (I)
Stock and Other Ownership Interests - illumina
Honoraria - Targeted Oncology
Consulting or Advisory Role - Guardant Health; Roche
Research Funding - Ventana Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent royalty related to immune markers in colon cancer. Patent jointly held between myself and Roche/Ventana Medical Systems. (Inst)
Travel, Accommodations, Expenses - Guardant Health
 
Bhavik Patel
No Relationships to Disclose
 
Thomas Westerling-Bui
Employment - Aiforia
 
Sameer Shivji
No Relationships to Disclose
 
James Conner
No Relationships to Disclose
 
Carol Jane Swallow
No Relationships to Disclose
 
Paul Savage
No Relationships to Disclose
 
David Patrick Cyr
No Relationships to Disclose
 
Richard Kirsch
Consulting or Advisory Role - Alimentiv
 
Reetesh Pai
Consulting or Advisory Role - Alimentiv